We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

News   Nov 28, 2017 | Original story from University of Illinois

 
Human Brain-cancer Patients Set to Receive Cancer Drug in Clinical Trials

Pretzel's brain tumor shrank more than 40 percent after treatment with PAC-1 in a clinical trial for dogs with glioma, a brain cancer very similar to glioblastoma in humans. Credit: Photo courtesy Tim Fan

 
 
 

RELATED ARTICLES

Compound Created to Block Therapeutic Target in Blood Cancer

News

Researchers have discovered a hyperactive cell signal that contributes to tumor growth in an aggressive blood cancer. The team has also developed an experimental therapeutic "UNC3810A" to block the signal and slow tumor growth.

READ MORE

Gene Test Identifies Prostate Cancer Patients Most Likely to Respond to New Treatment

News

Testing for genetic weaknesses in repairing DNA could identify men most likely to benefit from a new type of targeted nuclear medicine, a new study reports.

READ MORE

“Bloated” Cancer Cells May Have an Achilles' Heel

News

In a study using yeast cells and data from cancer cell lines, scientists report they have found a potential weak spot among cancer cells that have extra sets of chromosomes. The vulnerability is rooted in their high intracellular protein concentrations -- that make them appear bloated.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Cancer Research Drug Discovery Neuroscience

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE